Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

The purpose of this study is to determine the safety, tolerability, PK and pharmacodynamics of KK2223 in adult participants with relapsed or refractory peripheral T cell lymphoma (PTCL) or cutaneous T cell lymphoma (CTCL).

Participants needed: 72
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Kyowa Kirin, Inc.Updated: Jul 1, 2026Locations: 17
Eligibility criteria

Adults (≥18 years) with confirmed T-cell lymphoma subtypes: PTCL (including noda... [+9]

Recent autologous or allogeneic transplant within 120 days before treatment; act... [+15]

Status: Recruiting

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

This is a non-interventional cohort study evaluating non-relapse mortality and toxicities in patients with CTCL or ATLL treated with mogamulizumab pre- or post- alloHCT for patients transplanted beginning January 1, 2012 until accrual is complete.

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Kyowa Kirin, Inc.Updated: Jul 24, 2024Locations: 1Duration: 2 Years
Eligibility criteria

Patients registered to the Center for International Blood and Marrow Transplant... [+2]